ClinicalTrials.gg
Drug

Gedatolisib clinical trials

Also written PF-05212384 and PKI-587.

studies test it
18
open now
3
in phase 3
2
first study started
2010

How each study uses gedatolisib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the gedatolisib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Jul 2026 · REVTORPYK · NDA 219908 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Gedatolisib
10

Development codes

PF-05212384
10
PKI-587
5

Studies by the year they started

18 studies that test it; most in 2014 (3)

Studies that test gedatolisib, by start year
YearStudies
20101
20121
20131
20143
20151
20162
20172
20182
20192
20221
20241
20251

By phase

A phase 1/2 study counts in both.

Phase 1
12
Phase 2
9
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 9

Pfizer (5) · Celcuity Inc (4) · Dana-Farber Cancer Institute (2) · Kari Wisinski (1) · Kathy Miller (1) · Cristiana Sessa (1) · Institut Curie (1) · University of Florida (1)

Often tested with

Tested in the same studies.

Letrozole (2) · Abemaciclib (1) · Metformin (1) · Darolutamide (1) · Irinotecan (1) · FOLFIRI Regimen (1) · FOLFIRI-Ziv-aflibercept Regimen (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses gedatolisib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

Given beside what is tested · 2 — gedatolisib is usual care or a partner of the new treatment

Codes

What other systems call gedatolisib · ClinicalTrials.gg INT005609

  • MeSH (NLM) C549060gedatolisibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 96265TNH2RGEDATOLISIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q27077788gedatolisibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C91732GedatolisibOne source FDA
  • DrugBank DB11896One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.